Schedule 13G ownership disclosure
Lineage Cell Therapeutics Inc
Common · CUSIP: 53566P109
Event date: 2025-09-22
- Filing-level shares
- 11,445,003.00
- Percent of class
- 5.0%
- Chernett Jorey
Shares: 11,445,003.00 · Class: 5.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002042077-25-000004
- Form type
- SCHEDULE 13G
- Filer
- Chernett Jorey
- CIK
- CIK 2042077
- Filed
- Sep 26, 2025
- Reporting period
- Sep 22, 2025
- Description
- Schedule 13G beneficial ownership